A mild phenotype of dihydropyrimidine dehydrogenase deficiency and developmental retardation associated with a missense mutation affecting cofactor binding

Clin Biochem. 2011 Jun;44(8-9):722-4. doi: 10.1016/j.clinbiochem.2011.03.033. Epub 2011 Mar 21.

Abstract

Objectives: Evaluation of a non-synonymous mutation associated with dihydropyrimidine dehydrogenase (DPD) deficiency.

Design and methods: DPD enzyme analysis, mutation analysis and molecular dynamics simulations based on the 3D-model of DPD.

Results: The substitution Lys63Glu is likely to affect the FAD binding pocket within the DPD protein and contributes to a near-complete DPD deficiency in a patient with developmental retardation.

Conclusions: Like other DPD variants attenuating FAD binding, Lys63Glu should be included in screening for DPD deficiency.

Publication types

  • Case Reports

MeSH terms

  • Amino Acid Sequence
  • Child
  • Creatinine / urine
  • Dihydropyrimidine Dehydrogenase Deficiency / urine*
  • Dihydrouracil Dehydrogenase (NADP) / chemistry
  • Dihydrouracil Dehydrogenase (NADP) / genetics*
  • Dihydrouracil Dehydrogenase (NADP) / metabolism
  • Flavin-Adenine Dinucleotide / metabolism*
  • Genotype
  • Humans
  • Male
  • Molecular Sequence Data
  • Mutation, Missense / genetics*
  • Protein Binding / genetics
  • Protein Binding / physiology
  • Sequence Homology, Amino Acid
  • Thymine / urine
  • Uracil / analogs & derivatives
  • Uracil / urine

Substances

  • dihydrouracil
  • Flavin-Adenine Dinucleotide
  • Uracil
  • Creatinine
  • Dihydrouracil Dehydrogenase (NADP)
  • Thymine